Start at the beginning, and maybe read a bit more here. Almost without exception, drugs come with side effects. The question is whether the benefits outweigh the risks. In the case of Ozempic and other GLP-1 receptor agonists, the benefits for diabetics outstrip the positive elements of the older alternatives. On the risk side, Ozempic brings a degree of risk that is not substantially higher than other treatments for T2D. So on balance, there is normally a strong case to be made for Ozempic for almost every patient, based on the prescribing physician’s evaluation of the specifics relating to this person.